June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Longitudinal Automated Ellipsoid Zone Mapping Assessment in Retinal Vein Occlusions
Author Affiliations & Notes
  • Kathryn Champ
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Lucas Beven
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Rishi P Singh
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Touka Banaee
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Karen M Wai
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
    School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States
  • Sunil K Srivastava
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Jamie Reese
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Justis Ehlers
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Kathryn Champ, None; Lucas Beven, None; Rishi Singh, Alcon (F), Apellis (F), Genentech (C), Genentech (F), Optos (C), Regeneron (C), Regeneron (F), Shire (C), Zeiss (C); Touka Banaee, None; Karen Wai, None; Sunil Srivastava, Alcon (C), Allergan (F), Bausch and Lomb (C), Bausch and Lomb (P), Bioptigen (P), Leica (P), Saten (C), Synergetics (P), Zeiss (C); Jamie Reese, None; Justis Ehlers, Alcon (C), Alcon (F), Alimera (C), Allergan (C), Bausch and Lomb (P), Bioptigen (C), Bioptigen (P), Genentech (C), Genentech (F), Leica (C), Leica (P), Regeneron (F), Saten (C), Synergetics (P), Thrombogenics (C), Thrombogenics (F), Zeiss (C)
  • Footnotes
    Support  NIH/NEI K23-EY022947; Ohio Department of Development TECH-13-059
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1536. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Kathryn Champ, Lucas Beven, Rishi P Singh, Touka Banaee, Karen M Wai, Sunil K Srivastava, Jamie Reese, Justis Ehlers; Longitudinal Automated Ellipsoid Zone Mapping Assessment in Retinal Vein Occlusions. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1536.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the longitudinal quantitative dynamics of the ellipsoid zone (EZ) during management of macular edema in retinal vein occlusion (RVO) and the impact of EZ dynamics on functional outcomes.

Methods : In this IRB-approved retrospective study, a novel retinal layer analysis tool is utilized to evaluate the EZ characteristics longitudinally during the treatment of macular edema secondary to RVO. Inclusion criteria included RVO diagnosis, the presence of macular edema, and a minimum follow-up of 3-months (n=236). Exclusion criteria included lack of macular cube scans at baseline and 3-month follow-up periods (n=54). All eyes underwent macular OCT (Cirrus, Zeiss) at each follow-up interval. Macular cube scans were exported into a novel retinal layer analysis software and EZ parameters were evaluated with an automated platform. Expert reader review was performed on each scan to confirm accurate segmentation. The en face characteristics that were evaluated included percent of area with EZ-retinal pigment epithelium (RPE) attenuation (EZ-RPE thickness < 20 µm), percent of area with EZ-RPE total attenuation (EZ-RPE thickness = 0 µm), EZ-RPE volume, juxtafoveal EZ-RPE thickness, and central foveal EZ-RPE area and thickness. These EZ mapping parameters were analyzed for correlation with clinical data.

Results : One hundred eighty-two eyes were included in this study. All eyes were treated with anti-VEGF therapy at presentation. Initial visual acuity improved from 20/87 at baseline to 20/52 at 3-months (p<0.0001). The mean line change was +2.3 at 3-months. Following initiation of anti-VEGF therapy, EZ attenuation and total attenuation significantly improved by 8.2% (16.4 to 8.2%, p<0.0001) and 7.5% (12.9 to 5.4%, p<0.0001) respectively. The improvement in en face parameters significantly correlated with visual acuity improvement at 3 months. Visual recovery at each time point (e.g., 3, 6, and 12 months) was also strongly associated with improved central foveal EZ-RPE area (0.151mm2 to 0.180 mm2, p<0.0001) and increased EZ-RPE volume (1.044 mm3 to 1.134 mm3, p<0.0001).

Conclusions : EZ parameters and longitudinal dynamics are directly correlated to functional outcomes in the RVO. Further research is needed to better elucidate the predictive value of these parameters on overall outcomes and the role for assessment in disease management.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×